AstraZeneca Creates New Vaccines Division for Covid-19 Assets

AstraZeneca Plc is creating a new unit to house its coronavirus assets, after the pandemic spurred the British pharmaceutical giant to move into the vaccines space.

The company’s Covid-19 shot and antibody therapy will be placed in the new division, which will be run by executive Iskra Reic, Astra said in a statement Tuesday. The unit will house teams from the research, manufacturing and commercial departments.

“In order to optimize the management of our existing portfolio of vaccines and antibodies for viral respiratory infections, we are creating a dedicated vaccines and immune therapies unit,” Astra said. “The team will ...